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ABSTRACT
Candida albicans is the most common human fungal pathogen that can cause superficial and deep-seated infections in
susceptible individuals. Despite its medical importance, the vast majority of C. albicans genes remain of unknown function.
Here, we report a role for the lineage-specific gene, MRV8, in host pathogen interactions, mycelial microcolony maturation
and biofilm formation. In silico analysis indicated that MRV8 encodes a four-pass transmembrane protein unique to the
closely related pathogens C. albicans and Candida dubliniensis. Deletion of MRV8 did not affect C. albicans adherence to, or
initial invasion into human oral epithelia, but inhibited mycelial development and strongly reduced epithelial damage.
mrv8/ cells exhibited a media-dependent defect in biofilm formation and mutant biofilm metabolic activity was
enhanced by cyclosporin A. mrv8/ biofilms were more tolerant to treatment with caspofungin, but not to fluconazole or
amphotericin B. Co-stimulation with calcium chloride and calcofluor white rescued biofilm growth in the presence of
caspofungin, and this rescue-effect was Mrv8-dependent. Together, our data demonstrate an important role for a
lineage-specific gene (MRV8) in C. albicans biofilm formation, drug tolerance and host–pathogen interactions.
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INTRODUCTION
Candida albicans is normally a commensal member of the human
microbiota (mycobiota) and can cause disease when an imbal-
ance in host immunity or a disturbance of the normal microbiota
composition allows the transition to a pathogenic lifestyle (Gow
and Hube 2012). The pathogenicity of this fungus is mediated
by a number of factors including adhesion to host cells, inva-
sion and damage, which is predominantly caused by secretion
of the cytolytic toxin, candidalysin (Moyes et al. 2016). Biofilms
also play an important role in pathogenicity as they can serve as
reservoirs, driving recurrent candidaemia.
Biofilms are surface-associated communities of cells encased
within an extracellular matrix. Biofilm development emerges in
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several phases and can be divided into distinct stages. In early
stages, yeast cells adhere to the substratum forming the biofilm
basal layer, followed by co-aggregation of cells and coloniza-
tion. The intermediate stage is characterized by the formation of
hyphae and pseudohyphae and these filamentous cells continue
to develop to the mature stage when the biofilm exhibits a three-
dimensional structure composed of all three morphological cell
types embedded in extracellular matrix material. Finally, dis-
perser cells can be released from the biofilm to reinitiate the pro-
cess, or serve as an infection reservoir (For reviews, see: Mathe
and Van Dijck 2013; Desai, Mitchell and Andes 2014; Ramage,
Robertson and Williams 2014; Nobile and Johnson 2015; Gulati
and Nobile 2016; Soll and Daniels 2016).
Candida albicans biofilms can grow on host tissues, such as
epithelia and on abiotic medical and dental devices. The orga-
nization of the biofilm structure protects its inhabitants from
attack by host immunity and biofilms can exhibit extremely
high resistance to antifungal drugs. Indeed, C. albicans biofilms
can exhibit 30 to 200 times higher antifungal drug resistance
than planktonic cells (Hawser and Douglas 1995). Biofilm cells
are intrinsically resistant to fluconazole and sensitive only to
high concentrations of amphotericin B. On the other hand,
echinocandins, which inhibit cell wall β-glucan synthesis, and
amphotericin B lipid complexes are more effective at lower con-
centrations (Chandra et al. 2001; Kuhn et al. 2002; Lazzell et al.
2009; Uppuluri et al. 2011). The mechanisms of biofilm anti-
fungal resistance are not yet fully understood, but the resis-
tant phenotype has been linked to overexpression of drug tar-
gets, higher cell density, heterogeneous populations of cells
with different growth rates, expression of efflux pumps (CDR1–
2 and MDR1), extracellular matrix (especially β-glucan), which
sequesters antifungal drugs, subpopulations of persister cells,
and tolerance mediated by the molecular chaperone Hsp90
through regulation of the calcineurin pathway and its down-
stream transcription factor, Crz1 (Chandra et al. 2001; Nett et al.
2007; Singh et al. 2009; Nett et al. 2011; Robbins et al. 2011; Ram-
age et al. 2012; Taff et al. 2012; Tobudic et al. 2012; Mathe and Van
Dijck 2013).
Mrv8 (orf19.3908, C5 04250W) is a member of the MARVEL
(MAL and related proteins for vesicles trafficking and mem-
brane link) domain protein family. This family consists of eight
members and orthologues also exist in C. dubliniensis. Douglas,
Wang and Konopka (2013) reported that another family mem-
ber, Nce102, was involved in invasive growth, but did not find
altered phenotypes for the other family members. Our own
group reported that mrv8/ was defective for epithelial dam-
age (Wilson et al. 2014).
Here, we report a role for C. albicans Mrv8 in epithelial dam-




For generation of a mrv8/+MRV8 complemented strain, a
sequence containing the open reading frame and 376 base
pairs upstream and 282 base pairs downstream sequences were
amplified from SC5314 C. albicans genomic DNA using the Phu-
sion High Fidelity DNA Polymerase Kit (Finnzymes). The PCR
product was purified with the QIAquick PCR Purification kit (Qia-
gen) and then cloned into the Pcr2.TOPO vector (Invitrogen). The
plasmid was digested with Sall and MluI, following gel extraction
with the QIAquick Gel Extraction kit (Qiagen). The plasmid CIp10
was also digested with SalI and MluI and the restriction enzymes
were heat inactivated by incubation at 65◦C/20 min. Next, the
linearized plasmid was dephosphorylated with calf intestinal
alkaline phosphatase (New England BioLabs) and gel extracted
using the QIAquick Gel Extraction kit (Qiagen). The MRV8 insert
and CIp10 plasmid were ligated at 25◦C/30 min using the Quick
Ligation Kit (New England BioLabs). Five μl of the ligation pro-
duction was used to transform Escherichia coli DH5α and the pos-
itive clones were selected on LB agar [1% bacto-tryptone, 0.5%
yeast extract, 1% NaCl, 2% agar] plates supplemented with 50 μg
ml−1 ampicillin. The plasmid carrying the insert was re-isolated
using the miniprep (Peqlab) and midiprep (Qiagen) kit and con-
firmed by control digestions with StuI, NcoI, and MfeI. The plas-
mid was digested with StuI prior the transformation into the uri-
dine auxotrophic C. albicans strain mrv8/ura−. Positive clones
were selected on SD agar [2% glucose, 0.17% yeast nitrogen base,
0.5% ammonium sulfate, 2% agar] plates without amino acids
and correct integration was verified by PCR using primers RPF-
F1/URA3-F2 and MRV8-INT-F/RPF1-R1. The strains and primers
used in this study are listed in Table 1 and Table 2, respectively.
Biofilm development
Biofilms were grown as described previously (Nobile and
Mitchell 2005; Junqueira et al. 2011). The strains were cultivated
in YPD [1% yeast extract, 2% bacto-peptone, 2% D-glucose] at
30◦C/24 h. The cultures were adjusted to OD600 at 0.5 in Spi-
der medium [1% nutrient broth, 1% mannitol, 0.4% K2HPO4, pH
7.2] and 250 μl was added to the wells of a 96-well flat-bottom
microtiter plate (TPP) followed by incubation at 37◦C for 1.5 h
with shaking at 75 rpm (Quimis). After washing the wells, fresh
medium was added and the plate was incubated at 37◦C/48 h at
75 rpm. The medium was changed every 24 h.
The protocol for XTT colorimetric assay was described by Jin
et al. (2003). Briefly, the biofilms were washed twice and treated
with 197.5 μl of PBS, 50 μl of XTT (1 mg mL−1) (Sigma-Aldrich)
and 2.5 μl of menadione (0.4 mM) (Sigma-Aldrich) in the dark at
37◦C/3 h. Next, 100 μl of the supernatant was transferred to a
new well and the colorimetric change was measured at 492 nm
using a microtiter plate reader (Thermo Plate, TP Reader NM).
Scanning electron microscopy (SEM)
The biofilms were grown on gamma radiation-sterilized and 24 h
fetal bovine serum (FBS) (Sigma-Aldrich) pre-treated polystyrene
discs measuring 8 mm in diameter and 2 mm in thickness in
24-well plates (TPP) for 60 h at 37◦C with agitation. The biofilm
method was performed as described above with media and PBS
adjusted to 2 mL. First, the biofilms were photographed for visual
appearance analysis and, then, fixed in 2.5% glutaraldehyde for
1 h and dehydrated by alcohol solutions with increasing concen-
trations of ethanol (10%, 25%, 50%, 75% and 90% for 20 min, and
100% for 1 h). The discs were dried at 37◦C/24 h (Costa et al. 2011).
The discs were then transferred to aluminum stubs and covered
with gold for 120 s at 40 milliamps (BAL- TEC 50D 050 Sputter
Coater) and imaged with Jeol JSM5600.
Stress susceptibility
The spotting assay was carried out according to the method of
Wilson et al. (2014) on SD or YPD agar containing 1.5, 2 and 2.5 M
NaCl (Roth), 1.5, 2, 2.5 M Sorbitol (Roth), 2 mM H2O2, 450 μg ml−1
Congo red (Sigma-Aldrich), 800 μg ml−1 calcofluor white (CFW)
(Sigma-Aldrich), 3% ethanol, 0.1%–0.6% SDS (Sigma-Aldrich) and
incubated at 37◦C for up to 7 days. For UV stress, plates were
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Table 1. C. albicans strains used in this study.
Strain Genotype Reference
BWP17 + CIp30 ura3::/imm434/ura3::/imm434 arg4::hisG/arg4::hisG
his1::hisG/his1::hisG + CIp30
Mayer et al. (2012)
mrv8/ orf19.3908::ARG4/orf19.3908::HIS1 + CIp10 (URA3) Wilson et al. (2014)
mrv8/::MRV8 orf19.3908::ARG4/orf19.3908::HIS1 + CIp10 (ORF19.3908, URA3) This study
Table 2. Primers used in this study.
Primer Sequence Reference
MRV8-Rec-F GTCGACAGTAATCTATACATTACACAACC This study
MRV8-Rec-R ACGCGTATACCATCAGGGATGTTGC This study
MRV8-Int-F1 GTTGGGCTATTGGCGTTATTTGTG This study
RPF-F1 GAGCAGTGTACACACACACATCTTG Wilson et al. (2014)
RPF1-R1 CGCCAAAGAGTTTCCCCTATTATC This study
URA3-F2 GGAGTTGGATTAGATGATAAAGGTGATGG Gola et al. (2003)
HIS-F2 GGACGAATTGAAGAAAGCTGGTGCAACCG Gola et al. (2003)
HIS-R2 CAACGAAATGGCCTCCCCTACCACAG Gola et al. (2003)
ARG4-F2 GGATATGTTGGCTACTGATTTAGC Martin et al. (2011)
ARG4-R2 AATGGATCAGTGGCACCGGTG Gola et al. (2003)
(Bio-Link, Vilber-Lourmat) and incubated at 37◦C for up to 7 days.
Plates were incubated at 42◦C for 4–6 days to assess growth
under thermal stress. Heat shock was performed by incubating
serial 10-fold dilutions (range 106–101) at 55◦C for 10, 15, 20 and
30 min, followed by spotting onto YPD agar plates and incuba-
tion at 37◦C for up to 7 days. Each experiment was performed at
least twice.
Growth assay
For growth assays under nutrient limitation, agar containing
0.67% YNB plus ammonium sulfate without amino acids (Difco)
was supplemented with 2% glucose, 2% potassium acetate,
2% glycerol, 2% galactose, 2% maltose or 2% olive oil as car-
bon source. For alternative nitrogen sources, agar containing
yeast carbon base medium (Difco) was supplemented with 0.5%
BSA (Sigma-Aldrich), lysine (Sigma-Aldrich), histidine (Sigma-
Aldrich), glycine (Sigma-Aldrich), cysteine (Sigma-Aldrich) or
methionine (Sigma-Aldrich) at a concentration of 1 nM. Spot
dilution assays (range 106–101) were prepared and plates were
incubated at 37◦C/3–7 days depending on the carbon and nitro-
gen source. All experiments were repeated at least twice.
Filamentation assays
For the filamentation assays, the cells grown overnight in YPD
were washed twice in PBS and the cell density was determined
using a hemocytometer.
Filamentation on solid media was performed in the follow-
ing media and incubation times: Spider agar at 30 or 37 ◦C/7
days; agar supplemented with 10% FBS at 30 or 37◦C/7 days; YPS
agar [1% yeast extract, 2% bacto-peptone, 2% D(+)-saccharose,
2% agar] seeded by embedding at 25◦C/5 days (Chaput et al. 1983).
The colonies were analyzed visually and the experiments were
performed on two different occasions.
For filamentation analysis in liquid media, 5 × 104 fungal
cells were added per well in a 12- well cell culture plate con-
taining 10% FBS, YPD, YPD plus 10% FBS, Spider medium, Lee’s
medium at pH 6.5, RPMI-1640 medium (Invitrogen) or Dulbecco
Modified Eagle Medium (DMEM) and the plates incubated at
37◦C/3 h, with 5% CO2 for RPMI and DMEM. The percentage of
filament forms was determined by microscopy observation and
the length of the filaments was directly measured using LAS
software (Leica Application Suite). The experiments were per-
formed in duplicate and repeated twice.
Induction of filamentation was carried out on oral epithelial
cell monolayers (TR146) (Nicholls et al. 2009). These cells were
infected with 105 C. albicans cells and incubated at 37◦C/3- 6 h
with 5% CO2 atmosphere. The hyphal cells were then differen-
tially stained according to the invasion assay protocol described
below and the length of the hyphae measured using the LAS
software (Leica Application Suite). The experiment was per-
formed in triplicate on two different occasions.
For induction of hyphal micro-colonies, approximately 50
fungal cells were added to oral epithelial cell monolayers (TR146)
grown according to the invasion assay protocol described below.
The plates were incubated at 37◦C/24 h in the presence of 5%
CO2. Next, the cells were fixed with 4% paraformaldehyde and
stained with calcofluor white solution. Control micro-colonies
were grown on plastic and fixed with 4% paraformaldehyde prior
to observation. The dimensions of at least 50 micro-colonies
per strain were determined using an inverse microscope (Leica
DMIL) and the LAS software (Leica Application Suite). The tests
were performed on three different occasions.
Around 100 Candida cells were plated on a layer of Spider agar
or 10% FBS containing 1.5 or 4% agar and subsequently over-
laid with a second layer of medium for invasive growth analysis.
Plates were incubated at 30 and 37◦C/7 days. The colonies were
examined and photographed. The experiment was performed in
duplicate on two different occasions.
Antifungal tests on biofilm
Susceptibility of biofilms to antifungal drugs and growth in
the presence of different substances were verified using the
method described by Pierce et al. (2008). Briefly, overnight YPD
cultures were washed and resuspended in pre-warmed RPMI-
1640 buffered with MOPS (165 mM, pH 7.0) and adjusted to a con-
centration of 1 × 106 cells ml−1. One hundred microliters of the
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at 37◦C/24 h statically. Afterwards, 200 μl of the antifungal solu-
tions in RPMI was added to the washed biofilms and the plates
were incubated for additional 24 h at 37◦C. The biofilms were
exposed to the chemicals over the developing time, 48 h. After
the treatments, the biofilm metabolic activity was determined
by XTT assay as described above. To determine the quantity of
dispersed cells, the plate was shaken in an orbital shaker for
5 min (Solab). Aliquots of serial dilutions from the supernatant
were plated onto Sabouraud dextrose agar plates and incubated
at 37◦C/48 h to determine colony forming units.
The antifungal drugs fluconazole, amphotericin B and caspo-
fungin were used ranging from 2- 1024 mg l−1, 0.03125- 16 mg l−1,
and 0.0625- 32 mg l−1, respectively. The biofilms were treated
with the chemicals 75 μg ml−1 FK506, 20 μM nikkomycin Z,
0.025 M CaCl2, 12.5 μg ml−1 CFW and 75 μg ml−1 Cyclosporin
A, all of which were purchased from Sigma-Aldrich and the
stock solution prepared in distilled water, except for Cyclosporin
A and amphotericin B that were diluted in DMSO (Sigma-
Aldrich).
Oral epithelial cells: adherence, invasion and damage
The human buccal carcinoma epithelial cell lineage TR-146
(Cancer Research Technology, London) (Rupniak et al. 1985) was
used in the following methods and cultivated as described by
Wilson et al. (2014).
Invasion rates of the strains were determined and analyzed
as previously described by Park et al. (2005) and Mayer et al.
(2012).
For adherence assay, the counting of adhered cells was per-
formed using the slides prepared for the invasion assay at the
time point of 3 h. The number of adhered cells was determined
by counting 50 high power fields of 150 x 150 μm size on three
different occasions.
The method to examine epithelial cell damage infected with
Candida cells for 24 h has previously been described in detail
(Mayer et al. 2012).
Statistical analysis
Differences for the in vitro tests and host–pathogen interaction
experiments among the strains were analyzed by analysis of
variance (ANOVA) and the Tukey test. P values < 0.05 were con-
sidered to be statistically significant. GraphPad Prism version
6.00 program was used for the statistical analysis.
RESULTS
Mrv8 is required for C. albicans mycelial micro-colony
development and epithelial damage
As part of a larger attempt to characterise unknown function
genes in C. albicans, we had previously generated a mrv8/
mutant and found it to exhibit defective epithelial damage (Wil-
son et al. 2014).
We therefore generated a mrv8/+MRV8 complemented
strain and analysed the impact of MRV8 deletion on Candida-
epithelial interactions in greater detail.
During the early stages of infection (3 h), the mrv8/ mutant
adhered to and invaded epithelia and formed hyphae at rates
almost identical to that of the wild type (Fig. 1A–C). However, at
later phases mrv8/ caused significantly less epithelial dam-
age than the wild type, and complementation with a single copy
of MRV8 restored damage to near wild type levels (Fig. 1D). As
this damage defect was unlikely the result of impaired hypha
formation, adhesion or invasion during the early stages of the
interaction (Fig. 1A–C), we performed morphological analysis of
late phase C. albicans-epithelial interactions. We infected epithe-
lia with very low numbers of C. albicans yeast cells (around 50 per
well), and assessed the morphology and dimensions of resultant
micro-colonies formed by the different strains. Figure 1E shows
that, by 24 h post-infection, deletion of MRV8 resulted in signifi-
cantly smaller C. albicans micro-colonies on oral epithelia. To test
whether this defect was specific for growth on epithelium, we
repeated the experiment in cell culture medium on plastic sur-
faces in the absence of host cells. Again, the mrv8/ formed
smaller micro-colonies than the wild type and complemented
strains (Fig. 1E). These data indicate that Mrv8 is dispensable for
the initial filamentation, adhesion and invasion events associ-
ated with C. albicans-epithelial infection, but that the mutant’s
attenuated damage capacity is likely due to defective mycelial-
related growth.
Candida albicans MARVEL family member, Mrv8, is
involved in biofilm growth despite showing no other in
vitro defects
Having confirmed its role in epithelial damage, we next sought
to functionally characterise Mrv8. The mrv8/ mutant was
subject to exhaustive functional characterisation tests, reveal-
ing no altered phenotype compared to the wild type. mrv8/
was able to grow at wild type rates on yeast growth media
(YNB agar) in the presence of selected sole carbon sources,
such as glucose, potassium acetate, glycerol, galactose, mal-
tose or olive oil and on YCB agar in the presence of BSA and
the amino acids lysine, histidine, glycine, cysteine, or methio-
nine as sole nitrogen sources. This indicates that Mrv8 is dis-
pensable for yeast phase growth. The mrv8/ mutant formed
filamentous colonies comparable to the wild type on Spider
medium and serum-containing agar plates, as well as when
embedded in YPS-, Spider- or serum-agar. At the single cell
level, the mutant also formed hyphae of similar lengths in liq-
uid hypha-inducing media on a plastic surface, including 10%
FBS, YPD plus 10% FBS, Spider medium, Lee’s medium at pH
6.5, RPMI-1640 and DMEM with CO2. Deletion of MRV8 also
had no obvious impact on the ability of C. albicans to grow
in the presence of thermal stress, the osmotic stressors NaCl
and sorbitol, oxidative stress (H2O2), the cell wall stressors cal-
cofluor white and Congo Red, and the cell membrane stressors
ethanol and SDS or following exposure to UV radiation (data not
shown).
When tested for biofilm formation, mrv8/ exhibited lower
metabolic activity in Spider medium (Fig. 2A), but not in RPMI
(below). Upon visual inspection, mrv8/ biofilms appeared
aberrant and patchy biofilm compared to the wild type and
revertant strains (Fig. 2B). Scanning electron microscopy images
revealed a mature wild type biofilm coating the substrate
surface and consisting of yeast, pseudohyphae and hyphal
cells with evidence of extracellular matrix. In contrast, the
mrv8/ biofilm was sparse and consisted mainly of yeast
cells, with little evidence of filamentation. Complementa-
tion with a single copy of MRV8 resulted in an intermedi-
ate phenotype: the biofilm covered most of the underlying
substrate and all three morphotypes were present (Fig. 2B).









niversity of Exeter user on 11 August 2020
Costa et al. 5
Figure 1. Mrv8 is required for mycelial maturation and damage of oral epithelial cells. Host-pathogen interaction tests were performed on TR146 oral epithelial
cell monolayers. (A), Candida albicans cells adhered to host cells after 3 h of interaction were counted from 50 fields in three independent experiments. (B), The
percentage of invasive hyphae was determined by dividing the number of invaded cells by the total number of cells on epithelia. The results represent the mean ± SD
of three independent experiments performed in duplicate. (C), The length of hyphae grown on epithelia for 3 and 6 h was measured using LAS software on two
separate occasions carried out in triplicate. (D), Damage capacity was determined for TR146 monolayers infected with C. albicans cells for 24 h by measuring lactate
dehydrogenase (LDH) levels in the supernatant. Results are the mean ± SD of at least three independent experiments performed in triplicate. Difference statistically
significant for multiple comparisons, Tukey’s test ∗P < 0.001. (E), At least 50 microcolonies grown in DMEM medium for 24 h on epithelial cells or on plastic were
measured and the results expressed as the mean ± SD of at least three independent experiments. On epithelia, fungi were stained with calcofluor white. Representative
pictures of micro-colonies formed by the wild type, mutant and revertant strains, respectively, scale bars: 250 μm on TR146 and 50 μm on plastic. Difference statistically
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Figure 2. Effect of MRV8 deletion on C. albicans biofilm formation. (A), Metabolic
activity of Spider medium biofilms (48 h) as assessed by XTT assay expressed as
the mean ± SD of three independent experiments each performed in triplicate.
∗P < 0.01 and ∗∗P < 0.001, Tukey’s test. (B), Representative pictures of biofilms
grown on polystyrene discs in Spider medium for 60 h and scanning electron
microscopy (SEM) of biofilms grown under the same conditions showing a sparse
biofilm formed by the mrv8/ mutant composed of yeasts and pseudohyphae
in contrast to the mature biofilm formed by the wild type constituted by multi-
layers of yeasts, pseudohyphae and hyphae. Scale bars: 7 μm, 5000 x magnifica-
tion.
mrv8/ biofilms are less susceptible to caspofungin at
higher concentrations
In order to test the sensitivity of mrv8/ biofilms to antifun-
gal and chemical treatment, we formed biofilms in RPMI media
where, under control conditions, the mrv8/ mutant behaves
similarly to the wild type (Fig. 3).
One of the hallmarks of biofilm physiology is a high toler-
ance to antifungal drugs. We therefore next questioned whether
Mrv8 plays a role in C. albicans biofilm antifungal drug resis-
tance. To mimic a therapeutic, rather than prophylactic regime,
biofilms were first allowed to develop for 24 h and then treated
with different concentrations of antifungals for a further 24 h.
Next, biofilm integrity was assessed by XTT assay. Figure 3A
and B show that biofilms were fully resistant to fluconazole up
to the maximum tested concentration (1024 mg l−1) and exhib-
ited dose-responsive inhibition by amphotericin B. Biofilms of all
strains exhibited the characteristic eagle effect in the presence
of caspofungin, with drug tolerance increasing at higher concen-
trations. Interestingly, at several drug concentrations (Fig. 3C),
biofilms of mrv8/ exhibited increased caspofungin tolerance.
We also tested the sensitivity of planktonic cells to these three
drugs and observed no differences amongst the strains (data not
shown).
Caspofungin tolerance can be induced by a Ca2+/calcineurin
-mediated cell wall salvage pathway which causes an increase in
chitin content (Munro et al. 2007; Walker, Gow and Munro 2013;
Rueda, Cuenca-Estrella and Zaragoza 2014). As MRV8 encodes
a predicted plasma membrane protein, we reasoned that the
observed differences in caspofungin tolerance in the mrv8/
mutant may be due to altered Ca2+/calcineurin signaling and/or
chitin synthesis. In order to test this hypothesis, biofilms were
grown for 24 h in the presence of sub-inhibitory concentrations
of the calcineurin inhibitors, FK506 and cyclosporin A (CsA), the
chitin synthesis inhibitor, Nikkomycin Z or CaCl2/CFW (a com-
bination treatment which increases chitin synthesis and caspo-
fungin tolerance) (Walker et al. 2008), then treated further with
0.5 mg l−1 caspofungin and the chemicals for a further 24 h and
biofilm integrity assessed by measuring XTT activity.
Cyclosporin A treatment alone enhanced mrv8/ biofilm
formation compared to the wild type, whilst the other treat-
ments had no effect (Fig. 3D). Pre-treatment of biofilms with
cyclosporin A had no significant effect on caspofungin sensitiv-
ity whilst both FK506 and Nikkomycin Z increased its antifun-
gal effect. Interestingly, treatment of biofilms with the chitin-
stimulatory combination of Ca2+/CFW increased caspofungin
tolerance in wild type, but not in mrv8/ biofilms. This is
unlikely to be the result of defective chitin synthesis because
both chitin and calcium levels were high in mrv8/ yeast cells
following the co-stimulation (Fig. S1, Supporting Information).
Indeed, Ca2+/CFW-treatment significantly (P = 0.0285) enhanced
wild type biofilm tolerance against caspofungin by 5.3-fold but
had virtually no effect on mrv8/ biofilms (1.2-fold) and the
mrv8/+MRV8 complemented strain exhibited an intermedi-
ate (2.3-fold) increase in biofilm activity, which was not signifi-
cant.
We also determined biofilm dispersal under these different
treatment conditions (Fig. 3E). Overall, the level of dispersal
reflected biofilm activity as determined by XTT assay (Fig. 3D
vs. E). However, whilst caspofungin-treated mrv8/ biofilms
exhibited increased metabolic activity (Fig. 3D), they released
fewer disperser cells but this was not statistically significant
(Fig. 3E). Together, these data suggested that mrv8/ biofilms
may be associated with altered calcium/calcineurin signaling or
chitin synthesis in response to stimulation.
DISCUSSION
Candida albicans is a member of the CTG-Ser Clade of fungi—a
group which contains pathogens, non-pathogens, and species
with lower virulence than C. albicans. Because of this, our group
has postulated that lineage-unique genes may contribute to the
high virulence potential of C. albicans. In a previous study, we
deleted a series of lineage unique genes and found several of
them to be important for host cell damage. There, we observed
a reduction in epithelial and endothelial damage by a mrv8/
mutant (Wilson et al. 2014).
To examine the mechanism underlying this defect, the
mrv8/ and mrv8/+MRV8 strains were evaluated for adhe-
sion, invasion and filamentation in association with epithelia.
Complementation of mrv8/ with a single copy of MRV8 fully
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Figure 3. The effect of calcineurin-inhibition and chitin-inhibition and stimulation on Mrv8-dependent biofilm caspofungin tolerance. Biofilms were formed for 24 h
and then treated with the antifungal drugs fluconazole (mg l−1) (A), amphotericin B (mg l−1) (B), or caspofungin (mg l−1) (CSF) (C) for an additional 24 h. The susceptibility
of the biofilms to the drugs was then evaluated by measuring the metabolic activity with XTT-assay. The results are expressed as the percentage of growth in relation
to the control (100%). The experiments were performed in triplicate on three different occasions. Alternatively, biofilms were allowed to form for 24 h in the presence
of 0.75% DMSO, 75 μg ml−1 FK506, 75 μg ml−1 cyclosporin A, 20 μM Nikkomycin Z, or 0.025 M CaCl2/12.5 μg ml−1 CFW before treatment with 0.5 mg l−1 caspofungin
and the chemicals for a further 24 h. Biofilm metabolic activity (XTT assay [D]) or dispersal (CFU (Log10)/well [E]) was then determined. Results are the mean ± SD of
three independent experiments performed in triplicate. Difference statistically significant for multiple comparisons, Tukey’s test ∗P < 0.05.
due to MRV8 deletion. Adhesion, invasion and initial hypha
formation on epithelia was virtually identical for all strains,
indicating that early morphogenic events are independent of
Mrv8 function. However, at later phases of mycelial develop-
ment on epithelia, the mrv8/ mutant exhibited significantly
smaller micro-colonies. This was not an epithelial-specific phe-
nomenon, as mrv8/ micro-colonies were also reduced in size
in the absence of host cells. We propose that Mrv8 plays a
role in later stages of hyphal development, and the resultant
defects in hyphal maturation and ramification may account for
the epithelial damage defect of the mrv8/ mutant. These
defects in hyphal maturation may also contribute to the altered
biofilm phenotypes observed in this study. The precise mech-
anism by which Mrv8 contributes to hyphal maturation is cur-
rently unknown. Because Mrv8 is a predicted transmembrane
protein, it is possible that it acts as a sensor, relaying an extracel-
lular cue to the intracellular signal transduction pathways and
transcriptional machinery governing morphogenesis.
Deletion of MRV8 did not affect biofilm sensitivity to flucona-
zole or amphotericin B. Interestingly, however, mrv8/ exhib-
ited increased tolerance to inhibitory concentrations of caspo-
fungin (Fig. 3C).
Caspofungin targets β-1,3-glucan via inhibition of the cog-
nate synthase Fks1 and hot-spot mutations in FKS1 have been
associated with caspofungin resistance (Walker et al. 2008;
Walker, Gow and Munro 2013). Increased caspofungin toler-
ance can also be induced by elevations in cell wall chitin
(Walker et al. 2008). This cell wall salvage pathway is induced
by increased CHS1, CHS3, CHS2, and CHS8 expression, elevated
chitin synthase activity and increased chitin content in the
cell wall in response to caspofungin (Walker et al. 2008; Rueda,
Cuenca-Estrella and Zaragoza 2014). These events can be medi-
ated through the protein kinase C (PKC), high osmolarity glyc-
erol response (HOG), and Ca2+-calcineurin signaling pathways
(Walker et al. 2008; Walker, Gow and Munro 2013). Calcium
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results in Crz1-dependent induction of CHS2 and CHS8 (Munro
et al. 2007). We hypothesized that altered calcineurin signal-
ing may be involved in the caspofungin tolerance phenotype of
mrv8/ mutant biofilms.
In line with this, in the absence of caspofungin, cyclosporin
A treatment actually enhanced biofilm metabolic activity for
the mrv8/ mutant suggesting that calcineurin signaling may
indeed be altered in this strain.
Exposure to calcium and CFW is known to protect C. albicans
cells against caspofungin by increasing chitin synthesis (Munro
et al. 2007; Walker et al. 2008; Walker, Gow and Munro 2013;
Rueda, Cuenca-Estrella and Zaragoza 2014). We also observed
this protective effect with wild type, but not mrv8/ biofilms.
Therefore, in the absence of MRV8, CaCl2/CFW does not protect
C. albicans from caspofungin.
As MARVEL proteins are implicated in plasma membrane
organization and Mrv8 itself contains four predicted transmem-
brane helices (Douglas, Wang and Konopka 2013), it is possible
that this protein functions at the cell surface, sensing the cal-
cium/CFW signal and possibly signaling through the calcineurin
pathway.
In summary, we determined the association of a spe-
cific MARVEL family member with pathogenicity and biofilm
drug tolerance. MRV8 was involved in hyphal maturation
on both abiotic and epithelial surfaces, damage of epithe-
lial cells, and biofilm-associated caspofungin tolerance, pos-
sibly via interactions with calcium- and calcineurin signaling
pathways.
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